Rapid DNA Biochip Detects TB Drug Resistance Mutations
A newly developed DNA biochip offers a promising solution for the rapid screening of second-line drug resistance (SLDR) in Mycobacterium tuberculosis, offering faster detection and improved accuracy for multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB).